2m 2m 2m 2m 2m 2m 2m
SAB BIOTHERAP (SABS)
NASDAQ
$3.87$0.00 (0.00%)
Price as of Jun 23, 2026 7:25 PM EDT- $300.5MMarket Cap
- 123.30%1-Year Change
- BiotechnologyIndustry
SAB BIOTHERAP (SABS)
$3.87$0.00 (0.00%)
SABS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.87 | ||
Change | -$0.07 (-1.75%) | ||
Open | $3.83 | ||
High | $4.00 | ||
Low | $3.80 | ||
Previous Close | $3.93 | ||
Volume | 395,393 | ||
30-Day Average Volume | 887,153 | ||
1-Week Change | 0.77% | ||
1-Month Change | 0.77% | ||
1-Year Change | 123.30% | ||
3-Year Change | -54.17% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 76.5M | ||
Total Assets | $248.5M | ||
Market Cap | $300.5M | ||
Enterprise Value | $280.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.9M | ||
Free Cash Flow | -$15.3M | ||
EBIT | -$18.9M | ||
EBITDA | -$18.1M | ||
Net Working Capital | $102.9M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/05/2024 | ||
Earnings & Revenue